---
title: "Aspire Biopharma (ASBP.US) — 財務報表"
type: "Symbol"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/quote/ASBP.US/norm.md"
symbol: "ASBP.US"
name: "Aspire Biopharma"
parent: "https://longbridge.com/zh-HK/quote/ASBP.US.md"
datetime: "2026-03-04T02:00:34.595Z"
locales:
  - [en](https://longbridge.com/en/quote/ASBP.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/ASBP.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/ASBP.US/norm.md)
---

> 支持的語言: [English](https://longbridge.com/en/quote/ASBP.US/norm.md) | [简体中文](https://longbridge.com/zh-CN/quote/ASBP.US/norm.md)


# Aspire Biopharma (ASBP.US) — 財務報表

## 損益表 (USD)

| 指標 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
| --- | --- | --- | --- | --- | --- |
| 每股收益 | -1.49 | -1.61 | -16.83 | -0.0671 | -0.3134 |
| ROE | 70.21% | 95.66% | 1501.62% | 252.29% | 481.20% |
| 營業收入 | 1941.00 | - | - | - | - |
| 凈利潤 | -1.85M | -1.98M | -15.94M | -738500.00 | -216269.00 |
| 營業利潤 | -1.15M | -799890.00 | -1.43M | -640512.00 | -215256.00 |
| 毛利率 | 45.54% | - | - | - | - |
| 凈利率 | -95337.09% | - | - | - | - |
| 利潤含金量 | - | - | - | -133.56% | - |

## 資產負債表 (USD)

| 指標 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
| --- | --- | --- | --- | --- | --- |
| 資產與負債 | 2.40M | 989422.00 | 1.97M | 147989.00 | 184041.00 |
| 權益乘數 | -0.2096 | -0.1029 | -0.2827 | -0.0961 | -0.2296 |
| 每股凈資產 | -9.26 | -7.77 | -5.69 | -0.0035 | -0.0018 |
| 資產周轉率 | 0.0015 | - | - | - | - |
| 現金及短投 | 1.95M | 206233.00 | 1.35M | 3633.00 | 16541.00 |
| 存貨與應收 | 35437.00 | - | - | - | - |
| 長期投資 | - | - | - | - | - |
| 凈債務 | 6.68M | 8.27M | 5.42M | 1.26M | 836572.00 |

## 現金流量表 (USD)

| 指標 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
| --- | --- | --- | --- | --- | --- |
| 經營現金流 | -1.10M | -1.14M | -1.75M | 479569.00 | -495540.00 |
| 投資現金流 | - | - | - | - | - |
| 融資現金流 | 2.85M | 0.0000 | 3.09M | -492477.00 | 492477.00 |
| 自由現金流 | 2.76M | -685421.00 | 14.45M | -88447.00 | -458387.00 |
| 現金流充裕率 | -31.57% | - | -791.15% | - | - |
| 舉債與償債 | 7.25M | 0.0000 | 3.05M | -492477.00 | 492477.00 |
| 資本支出 | - | - | - | - | - |